Evidence map›Paper›PMID 28049648›Full record

ArticleJournal of the American Society of Nephrology : JASN2017

Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis.

Sagar U Nigwekar, Donald B Bloch, Rosalynn M Nazarian, Cees Vermeer, Sarah L Booth, Dihua Xu, Ravi I Thadhani, Rajeev Malhotra

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 72 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 3 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02278692 nacompletednot on this map

Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy

TypeinterventionalSponsorMassachusetts General HospitalRan2015 to 2019Enrolled26ConditionsCalciphylaxis, Calcific Uremic ArteriolopathyArmsVitamin K, Placebo
NCT03032835 recruitingnot on this map

Partners Calciphylaxis Biobank and Patient Registry

Typeobservational_patient_registrySponsorMassachusetts General HospitalRan2017 to 2030Enrolled300ConditionsCalciphylaxis, Calcific Uremic Arteriolopathy, End Stage Renal Disease, Chronic Kidney Diseases
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 3 syntheses or guidelines pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Sagar U NigwekarDivisions of *Nephrology, snigwekar@mgh.harvard.edu.
Donald B BlochRheumatology, Allergy and Immunology, and.
Rosalynn M NazarianPathology Service, Dermatopathology Unit, Massachusetts General Hospital, Boston, Massachusetts.
Cees VermeerR&D Group VitaK, Biopartner Center Maastricht, Maastricht University, Maastricht, The Netherlands; and.
Sarah L BoothVitamin K Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.
Dihua XuDivisions of *Nephrology.
Ravi I ThadhaniDivisions of *Nephrology.
Rajeev MalhotraCardiology, and.
Massachusetts General Hospital · USMaastricht University · NLPediatric Nephrology of Alabama · USTufts University · US

Funding

Harvard Clinical and Translational Science CenterKL2TR001100 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$8.5M
Modulation of Hepcidin-Ferroportin Signaling using Small MoleculesR01DK082971 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BLOCH, DONALD B, PETERSON, RANDALL T · 2009 to 2018
$4.5M
Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin DR01DK094486 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KARUMANCHI, S. ANANTH, THADHANI, RAVI · 2012 to 2018
$2.9M
The Role of Bone Morphogenetic Proteins in Vascular CalcificationK08HL111210 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MALHOTRA, RAJEEV · 2014 to 2018
$796k
Patient Oriented Studies of Vitamin D in Chronic Kidney DiseaseK24DK094872 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI THADHANI, RAVI · 2012 to 2016
$546k
NCATS NIH HHS KL2 TR001100NHLBI NIH HHS K08 HL111210NIDDK NIH HHS K24 DK094872NIDDK NIH HHS R01 DK082971NIDDK NIH HHS R01 DK094486
6 · The paper itself

Abstract

Matrix Gla protein (MGP) is a potent inhibitor of vascular calcification. The ability of MGP to inhibit calcification requires the activity of a vitamin K-dependent enzyme, which mediates MGP carboxylation. We investigated how MGP carboxylation influences the risk of calciphylaxis in adult patients receiving dialysis and examined the effects of vitamin K deficiency on MGP carboxylation. Our study included 20 patients receiving hemodialysis with calciphylaxis (cases) and 20 patients receiving hemodialysis without calciphylaxis (controls) matched for age, sex, race, and warfarin use. Cases had higher plasma levels of uncarboxylated MGP (ucMGP) and carboxylated MGP (cMGP) than controls. However, the fraction of total MGP that was carboxylated (relative cMGP concentration = cMGP/[cMGP + uncarboxylated MGP]) was lower in cases than in controls (0.58±0.02 versus 0.69±0.03, respectively;

Indexed as

CalciphylaxisCalcium-Binding ProteinsCarboxylic AcidsExtracellular Matrix ProteinsFemaleHumansMaleMatrix Gla ProteinMiddle AgedRiskVitamin KCalcium-Binding ProteinsCarboxylic AcidsExtracellular Matrix ProteinsMatrix Gla ProteinVitamin Kcalcific uremic arteriolopathycalcium-binding proteinrenal dialysisvascular calcificationvitamin Kwarfarin

Identifiers

PMID28049648
PMCPMC5461787
OpenAlexW2566951555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.